Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19

The emergence of the COVID-19 pandemic has led to significant uncertainty among physicians and patients about the safety of immunosuppressive medications used for the management of dermatologic conditions. We review available data on commonly used immunosuppressants and their effect on viral infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Galimberti, Fabrizio, McBride, Jeffrey, Cronin, Megan, Li, Yumeng, Fox, Joshua, Abrouk, Michael, Herbst, Alexander, Kirsner, Robert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
COVID-19: Important Updates and Developments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224642/
https://www.ncbi.nlm.nih.gov/pubmed/32419721
http://dx.doi.org/10.1016/j.clindermatol.2020.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224642/
https://www.ncbi.nlm.nih.gov/pubmed/32419721
http://dx.doi.org/10.1016/j.clindermatol.2020.05.003

Ejemplares similares